Resource Center
Resource Center
As with all health programs in South Africa and many around the world, COVID-19 had a significant impact on the delivery of reproductive, maternal, and neonatal services in 2020.
Read more
Introducing the fifth edition of CHAI’s HIV Mid-Year Market Memo, a brief that covers the latest trends in the HIV space in low- and middle-income countries since the publication of CHAI’s annual HIV Market Report in September 2020.
Read more
Our monthly check-in with staff from around the world. Learn more about the people who work at CHAI.
Read more
Under the UK Aid-funded AT2030 program, CHAI has developed case studies to highlight interventions successful in driving the availability and affordability of assistive technology products and services.
Read more
The Southern African Journal of HIV Medicine has published a CHAI-led study reflecting on the progress South Africa has made towards eliminating HIV.
Read more
The expanded partnership will increase access to leading-edge cancer treatments in low- and middle-income countries including biologics and hormonal therapies.
Read more
In 2019, CHAI launched our cervical cancer program with support from Unitaid. We partnered with governments in seven low-and-middle income countries to scale up safe, effective, and affordable pre-cancer screening and treatment technologies and assist partner governments in achieving global cervical cancer elimination targets, aiming to reduce the rate of premature mortality from the disease by a third.
Read more
This webinar highlights key HIV market trends in low- and middle-income countries as well as a panel discussion focusing on what comes next as the global community grapples with both HIV and COVID-19.
Read more
CHAI is helping slow the spread of AMR by ensuring patients have access to treatment and adhere to medicine regimens. Our approach is informed by insights learned from our work around AMR among pregnant women infected with syphilis.
Read more
The report looks at the complex, ever-changing antiretroviral and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work in over 30 countries.
Read more